| Cat.No.: | EAb-0508 |
| Product Name: | Lysine (K)-specific Demethylase 4C/KDM4C/JMJD2C Polyclonal Antibody |
| Antibody Type: | Polyclonal |
| Immunogen: | A genomic peptide made to an internal region of the human JMJD2C protein (within residues 450-600). [Swiss-Prot Q9H3R0] |
| Host: | Rabbit |
| Isotype: | IgG |
| Antibody Target: | KDM4C |
| Purification: | Immunogen affinity purified |
| Appearance: | Liquid |
| Formulation: | PBS and 50% Glycerol |
| Applications: | WB, Simple Western, ChIP, ICC/IF, IHC, IHC-P, IP |
| Recommended Dilutions/Conditions: |
Western Blot 1:10000; Simple Western 1:12.5; Chromatin Immunoprecipitation; Immunocytochemistry/Immunofluorescence 1:100; Immunohistochemistry 1:100; Immunohistochemistry-Paraffin 1:100; Immunoprecipitation Recommended dilutions/conditions may not be available for all applications. Specific conditions for reactivity should be optimized by the end user. |
| Species Reactivity: | Human, Mouse |
| Storage: | -20°C |
| Storage Buffer: | 0.05% Sodium Azide |
| Warning: | For Research Use Only! Not For Use in Humans. |
| Alternative Name: | EC 1.14.11; EC 1.14.11.-; GASC-1 protein; GASC1; GASC1JmjC domain-containing histone demethylation protein 3C; Gene amplified in squamous cell carcinoma 1 protein; JHDM3C; JMJD2C; JMJD2CbA146B14.1; jumonji domain containing 2C; Jumonji domain-containing protein 2C; KDM4C; KIAA0780FLJ25949; Lysine (K)specific Demethylase 4C; Lysine (K)-specific Demethylase 4C; lysine-specific demethylase 4C |
| Scientific Background: | JMJD2C (Jumonji C domain-containing oxygenase D2C; also called GASC1, JHDM3C or KDM4C) belongs to JMJD2 family and is a histone demethylase for di- and trimethylated lysine 9 and 36 on histone H3 (H3K9me3/2 and H3K36me3/2). H3K9me3/2 is generally associated with transcriptional repression and heterochromatin formation, whereas, H3K36me3/2 is linked to transcriptionaly active genes where it plays a key role in suppression of incorrect transcription. JMJD2C regulates the expression of pluripotency genes including NOTCH1, NANOG, Sox2 and Pou5, and because of its dual role in modifying H3 either by removing the repressive H3K9me3/2 or the active H3K36me3/2 factor, JMJD2C has been considered a fine-tuning regulator of gene expression in normal development/differentiation as well as in carcinogenic progression. JMJD2C is overexpressed in aggressive, basal-like breast cancers compared with non basal-like breast cancers, and its overexpression has been shown to cause transformation of immortalized, non-transformed mammary epithelial cells and to regulate expression of genes responsible for stem cell phenotype/self-renewal in breast cancer cells. Moreover oncogenic role of JMJD2C has been documented in prostate cancer where it enhances the transcription of AR-dependent genes and cell proliferation by interaction with ligand-bound AR. |
| Product Types | ||
| ◆ Cell Lines | ||
| CL-0015 | Human KDM5B Knockout Cell Line 14bp deletion | Inquiry |
| ◆ Bioactive Small Molecules | ||
| BSM-0027 | UNC0321 (trifluoroacetate salt) | Inquiry |
| ◆ Antibodies | ||
| EAb-0071 | KDM1B Polyclonal Antibody | Inquiry |
| EAb-0072 | JMJD6 Polyclonal Antibody | Inquiry |
| EAb-0074 | JMJD2c Polyclonal Antibody | Inquiry |
| Related Gene / Proteins | |||
| JMJD | JMJD1A | JMJD1B | JMJD1C |
| JMJD2 | JMJD2A | JMJD2B | JMJD2C |
| JMJD2D | JMJD2E | JMJD2F | JMJD3 |
| JMJD4 | JMJD5 | JMJD6 | KDM1 |
| KDM1A | KDM1B | KDM2 | KDM2A More > |
| KDM2B | KDM3A | KDM3B | KDM4 |
| KDM4A | KDM4B | KDM4C | KDM4D |
| KDM4E | KDM5 | KDM5A | KDM5B |
| KDM5C | KDM5D | KDM6A | KDM6B |
| KDM6C | KDM7 | KDM7A | KDM7B |
| KDM8 | |||
USA
Enter your email here to subscribe.
Follow us on
Easy access to products and services you need from our library via powerful searching tools
